Innoviva, Inc. (INVA) reporting calendar
Innoviva, Inc. files periodic reports with the SEC as INVA on Nasdaq. Atlas tracks 55 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 24 Jul 2026 – 19 Aug 2026
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 6 May 2026
- Reports on record
- 55
How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 37 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Open INVA market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 6 May 2026 | 36 days | 0001193125-26-209110 |
| 10-K | 31 Dec 2025 | 25 Feb 2026 | 56 days | 0001193125-26-071776 |
| 10-Q | 30 Sep 2025 | 5 Nov 2025 | 36 days | 0001193125-25-267040 |
| 10-Q | 30 Jun 2025 | 6 Aug 2025 | 37 days | 0000950170-25-104126 |
| 10-Q | 31 Mar 2025 | 7 May 2025 | 37 days | 0000950170-25-065765 |
| 10-K | 31 Dec 2024 | 26 Feb 2025 | 57 days | 0000950170-25-027864 |
| 10-Q | 30 Sep 2024 | 6 Nov 2024 | 37 days | 0000950170-24-122375 |
| 10-Q | 30 Jun 2024 | 31 Jul 2024 | 31 days | 0000950170-24-088661 |
| 10-Q | 31 Mar 2024 | 8 May 2024 | 38 days | 0000950170-24-055832 |
| 10-K | 31 Dec 2023 | 29 Feb 2024 | 60 days | 0000950170-24-023237 |
| 10-Q | 30 Sep 2023 | 1 Nov 2023 | 32 days | 0000950170-23-057530 |
| 10-Q | 30 Jun 2023 | 2 Aug 2023 | 33 days | 0000950170-23-037296 |
| 10-Q | 31 Mar 2023 | 9 May 2023 | 39 days | 0000950170-23-019835 |
| 10-K | 31 Dec 2022 | 28 Feb 2023 | 59 days | 0000950170-23-005168 |
| 10-Q | 30 Sep 2022 | 9 Nov 2022 | 40 days | 0000950170-22-023933 |
| 10-Q | 30 Jun 2022 | 27 Jul 2022 | 27 days | 0000950170-22-013224 |
| 10-Q | 31 Mar 2022 | 5 May 2022 | 35 days | 0000950170-22-007798 |
| 10-K | 31 Dec 2021 | 28 Feb 2022 | 59 days | 0000950170-22-002169 |
| 10-Q | 30 Sep 2021 | 27 Oct 2021 | 27 days | 0000950170-21-002378 |
| 10-Q | 30 Jun 2021 | 29 Jul 2021 | 29 days | 0001104659-21-097200 |
| 10-Q | 31 Mar 2021 | 28 Apr 2021 | 28 days | 0001104659-21-056556 |
| 10-K | 31 Dec 2020 | 25 Feb 2021 | 56 days | 0001104659-21-028328 |
| 10-Q | 30 Sep 2020 | 28 Oct 2020 | 28 days | 0001104659-20-118989 |
| 10-Q | 30 Jun 2020 | 29 Jul 2020 | 29 days | 0001104659-20-087867 |
| 10-Q | 31 Mar 2020 | 29 Apr 2020 | 29 days | 0001104659-20-053388 |
| 10-K | 31 Dec 2019 | 19 Feb 2020 | 50 days | 0001104659-20-022807 |
| 10-Q | 30 Sep 2019 | 30 Oct 2019 | 30 days | 0001104659-19-057833 |
| 10-Q | 30 Jun 2019 | 24 Jul 2019 | 24 days | 0001410578-19-000553 |
| 10-Q | 31 Mar 2019 | 1 May 2019 | 31 days | 0001104659-19-026029 |
| 10-K | 31 Dec 2018 | 19 Feb 2019 | 50 days | 0001047469-19-000541 |
| 10-Q | 30 Sep 2018 | 31 Oct 2018 | 31 days | 0001104659-18-065095 |
| 10-Q | 30 Jun 2018 | 26 Jul 2018 | 26 days | 0001104659-18-047409 |
| 10-Q | 31 Mar 2018 | 4 May 2018 | 34 days | 0001104659-18-030346 |
| 10-K | 31 Dec 2017 | 23 Feb 2018 | 54 days | 0001047469-18-001016 |
| 10-Q | 30 Sep 2017 | 3 Nov 2017 | 34 days | 0001104659-17-066031 |
| 10-Q | 30 Jun 2017 | 8 Aug 2017 | 39 days | 0001104659-17-050288 |
| 10-Q | 31 Mar 2017 | 5 May 2017 | 35 days | 0001104659-17-030290 |
| 10-K | 31 Dec 2016 | 28 Feb 2017 | 59 days | 0001047469-17-001057 |
| 10-Q | 30 Sep 2016 | 3 Nov 2016 | 34 days | 0001104659-16-154640 |
| 10-Q | 30 Jun 2016 | 4 Aug 2016 | 35 days | 0001104659-16-137049 |
Source: SEC EDGAR company submissions for CIK 0001080014. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.